Cancer Research

Can CAR-T Therapy Innovation Bridge the Gap in Cancer Care?
Research & Development Can CAR-T Therapy Innovation Bridge the Gap in Cancer Care?

A landmark 300 billion won donation from the late Samsung Chairman Lee Kun-hee has established a vital safety net for pediatric cancer patients across South Korea. This massive philanthropic contribution arrived at a critical juncture for families facing the devastating reality of

Regions Bank Pledges $2.5 Million to UMMC Cancer Center
Management & Regulatory Regions Bank Pledges $2.5 Million to UMMC Cancer Center

Regions Bank, a member of the S&P 500 with $161 billion in assets, is leveraging its financial footprint to address the systemic health challenges facing the Southern United States. This commitment takes the form of a historic $2.5 million pledge to the University of Mississippi Medical Center,

How Effective Is Sacituzumab Govitecan in Metaplastic Breast Cancer?
Research & Development How Effective Is Sacituzumab Govitecan in Metaplastic Breast Cancer?

Even after adjusting for age and prior therapy lines, metaplastic histology remains a clear indicator of a poor response to the Trop-2-directed antibody-drug conjugate sacituzumab govitecan. This finding, derived from a comprehensive retrospective analysis at the Massachusetts General Hospital

Neck Surgery Linked to Brain Waste Buildup and Mental Decline
Research & Development Neck Surgery Linked to Brain Waste Buildup and Mental Decline

For years, surgeons have treated the neck primarily as a structural corridor or a gateway for life-saving cancer interventions, unaware that this narrow passage also functions as the brain's essential metabolic exhaust pipe. A groundbreaking study from Weill Cornell Medicine has revealed that

Is Triplet Therapy the New Standard for HRR-Mutated mHSPC?
Research & Development Is Triplet Therapy the New Standard for HRR-Mutated mHSPC?

The discovery of a germline mutation in a prostate cancer patient facilitates cascade testing for family members who may be at risk for breast, pancreatic, or ovarian cancers. This clinical reality highlights the expanding role of genetic identification as a cornerstone of modern oncology, moving

Can Logic-Gating Overcome CAR-T Challenges in Solid Tumors?
Research & Development Can Logic-Gating Overcome CAR-T Challenges in Solid Tumors?

The appointment of industry veterans from Bristol Myers Squibb and Iovance Biotherapeutics highlights a major transition toward clinical-stage operations for cell therapy developers. This leadership influx comes at a pivotal moment for Link Cell Therapies as it progresses into the Phase I clinical

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later